Compare Crispr Therapeutics AG (CRSP) vs Expeditors International of Wshngtn Inc (EXPD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Expeditors International of Wshngtn Inc — how do they compare? Crispr Therapeutics AG trades at $54.08 (market cap $5.23B), while Expeditors International of Wshngtn Inc trades at $177.86 (market cap $23.04B). The key difference: Expeditors International of Wshngtn Inc is far larger — about 4.4× Crispr Therapeutics AG's market cap, and Expeditors International of Wshngtn Inc pays a 0.91% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.
| CRSP | EXPD | |
|---|---|---|
Market Cap | $5.23B | $23.04B |
Sector | Health | Industrials |
52-Week High | $76.78 | $182.80 |
52-Week Low | $44.34 | $113.13 |
Enterprise Value | $3.65B | $22.57B |
Dividend Yield | — | 0.91% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Expeditors International of Wshngtn Inc
Expeditors International of Washington is a non-asset-based third-party logistics provider, mainly focused on international freight forwarding. It employs sophisticated IT systems and contracts with airlines and ocean carriers to move customers' freight across the globe. The firm operates more than 200 full-service office locations worldwide, in addition to numerous satellite locations. In 2021, Expeditors derived 38% of consolidated net revenue from airfreight, 27% from ocean freight, and 35% from customs brokerage and other services.
Read more on EXPD →
